Market Executive Summary

REPORT HIGHLIGHT
The cholera vaccines market is estimated to represent a global market of USD 1,367.8 million by 2028 with growth rate of 10.3%. Cholera is a bacterial infection (Vibrio cholerae), primarily caused due to the contaminated food or water intake. Symptoms of it can be mild i.e. watery diarrhea and profuse vomiting, but it can lead to be severe. Normally, patients are treated with oral rehydration solution and in severe condition intake of intravenous fluid is required.
The market is divided into products such as Dukoral, Shanchol, Vaxchora and others. Dukoral, and Shanchol dominated the market. WHO has pre-qualified these two cholera vaccines which will support the market growth. Dukoral was the first oral cholera vaccine to get approval in European Union (EU) during the year 2004.
Geographically, North America and Europe recorded highest revenue of the total market. Of which, Europe dominated the market with more than USD 210 million revenue in 2017. Developing regions such as Asia Pacific and Latin America are considered to be the fastest growing regional segment owing to the high cholera incidences. For instance, as per the World Health Organization (WHO) statisticscholera spread very rapidly in Latin America which cause nearly 400,000 reported cases and over 4000 reported deaths every year. This fact would in turn boost the demand for cholera vaccines in developing regions, leading to drive the market growth.
Companies such as Merck & Co., GlaxoSmithKline, Sanofi and Pfizer, Inc. are the key players of the market. Collectively these companies accounted for more than 75% revenue share of the global market. Additionally, Novartis AG, Astellas Pharma, Emergent BioSolutions, Takeda Pharmaceuticals, AstraZeneca plc and Mitsubishi Tanabe have also significant presence in this market.
The market size and forecast for each segment has been provided for the period 2014 to 2028, considering 2017 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2017 to 2028 for every reported segment.
The years considered for the study are:
Historical Year ? 2014 & 2017
Base Year ? 2017
Estimated Year ? 2017
Projected Year ? 2028
TARGET AUDIENCE
Hospitals
Manufacturers
Traders, Distributors, And Suppliers
Government and Regional Agencies and Research Organizations
Consultants
Distributors
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
MARKET,BY PRODUCTS
Dukoral
Shanchol
Vaxchora
Others
MARKET,BY REGION
North America
Europe
Asia Pacific
Rest of the World
MARKET,BY COUNTRY
Further Breakdown of The North America Market
U.S.
Canada
Further Breakdown of The Europe Market
Germany
France
Rest of Europe
Further Breakdown of The APAC Market
India
China
Rest of APAC
Further Breakdown of The Rest of the World Market
Middle East and Africa
Latin America